Your browser doesn't support javascript.
loading
Biomarkers for Hepatocellular Carcinoma.
Lou, Jiatao; Zhang, LingFei; Lv, Shaogang; Zhang, Chenzi; Jiang, Shuai.
Afiliación
  • Lou J; Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang L; Center for RNA Research, State Key Laboratory of Molecular Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Lv S; Department of Anatomy, Histology & Embryology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang C; Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Jiang S; Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Biomark Cancer ; 9: 1-9, 2017.
Article en En | MEDLINE | ID: mdl-28469485
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis prediction. Furthermore, it might represent certain therapeutic interventions through some combinations of biomarkers. Here, we review on our current understanding of HCC biomarkers.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Biomark Cancer Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Biomark Cancer Año: 2017 Tipo del documento: Article País de afiliación: China